Logo

Maybe It Would Be Better If They Threw in a Year's Supply of Turtle Wax

May 01, 2008

In this story, the Wall Street Journal poses (and attempts to answer) this question: Which genetic tests are worth taking? The article notes that while "critics argue that many tests can't accurately identify which people are at risk for various illnesses," proponents say that well-established tests allow patients to take action for particular susceptibilities.

While WSJ considers the overall concept, Portfolio magazine is in the middle of a series about people dealing with genetic testing. In the latest installment, author David Ewing Duncan considers the results he got back from 23andMe and DecodeMe.

 

Breaking News
The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.